A new Northwestern Medicine study publishing in Nature Medicine suggests a promising alternative to previous attempts to ...

A UTA, University of California–San Francisco study explores why some nerve cells are more vulnerable to neurodegeneration ...

A new study suggests that women who use a popular hormonal menopause treatment later in life may be at a higher risk of developing Alzheimer’s disease.

Menopause hormonal therapy found linked to Alzheimer’s risk - Researchers hope findings could help optimise menopausal ...

For Alzheimer’s, blood tests for p-tau are still useful, but they should not be the only method for diagnosis. A positive ...

Researchers at Northwestern University have made a breakthrough in identifying a way for Alzheimer's disease to be treated ...

The results of a new study show that suppressing KCTD20, which responds to the neurotransmitter glutamate, activates a mechanism for expelling tau proteins.

The neurotransmitter glutamate is essential for regulating everything from mood to memory, but it can also encourage a toxic buildup of protein, which can contribute to Alzheimer's and related ...

"Studies have shown that vulnerability to Alzheimer's-related changes in the brain increase in women from pre- to ...

After Eli Lilly and Biogen’s setbacks in developing O-GlaNAcase (OGA) inhibitors for Alzheimer’s disease, Asceneuron has now ...

Researchers identified a gene that seems to help slow brain aging in women, and studied links between hormone therapy, ...

A special edition of the journal Science focuses on women's health, including links between estrogen and dementia, at a time ...